1. Home
  2. CGEN vs MGYR Comparison

CGEN vs MGYR Comparison

Compare CGEN & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • MGYR
  • Stock Information
  • Founded
  • CGEN 1993
  • MGYR 1922
  • Country
  • CGEN Israel
  • MGYR United States
  • Employees
  • CGEN N/A
  • MGYR N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • MGYR Savings Institutions
  • Sector
  • CGEN Health Care
  • MGYR Finance
  • Exchange
  • CGEN Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • CGEN 125.3M
  • MGYR 112.5M
  • IPO Year
  • CGEN 2000
  • MGYR 2006
  • Fundamental
  • Price
  • CGEN $1.95
  • MGYR $16.86
  • Analyst Decision
  • CGEN
  • MGYR
  • Analyst Count
  • CGEN 0
  • MGYR 0
  • Target Price
  • CGEN N/A
  • MGYR N/A
  • AVG Volume (30 Days)
  • CGEN 560.3K
  • MGYR 2.7K
  • Earning Date
  • CGEN 11-11-2025
  • MGYR 10-30-2025
  • Dividend Yield
  • CGEN N/A
  • MGYR 2.12%
  • EPS Growth
  • CGEN N/A
  • MGYR 35.01
  • EPS
  • CGEN N/A
  • MGYR 1.57
  • Revenue
  • CGEN $22,144,000.00
  • MGYR $35,533,000.00
  • Revenue This Year
  • CGEN N/A
  • MGYR N/A
  • Revenue Next Year
  • CGEN $208.08
  • MGYR N/A
  • P/E Ratio
  • CGEN N/A
  • MGYR $10.85
  • Revenue Growth
  • CGEN N/A
  • MGYR 18.29
  • 52 Week Low
  • CGEN $1.13
  • MGYR $12.10
  • 52 Week High
  • CGEN $2.66
  • MGYR $19.04
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 60.17
  • MGYR 40.86
  • Support Level
  • CGEN $1.30
  • MGYR $17.05
  • Resistance Level
  • CGEN $2.38
  • MGYR $17.04
  • Average True Range (ATR)
  • CGEN 0.17
  • MGYR 0.11
  • MACD
  • CGEN 0.04
  • MGYR -0.05
  • Stochastic Oscillator
  • CGEN 57.00
  • MGYR 0.00

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: